Progression of Large Lymphoma Is Significantly Impeded with a Combination of Gemcitabine Chemotherapy and Dendritic Cells Intra-Tumor Vaccination

Relapsed, refractory lymphoma remains to be a challenge and lacks efficient treatment. Some tumor cells escape from treatment, become resistant to chemotherapeutic agents, and rapidly regenerate into large tumors. Lymphoma cells induce accumulation of Gr-1(+)CD11b(+) myeloid derived suppressor cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xue-Jun, Yang, Zhong-Fa, Zhou, Jin-Yong, Liu, Li, Sun, Xue-Mei, Fan, Zhen-Fang, Hu, Shou-You, Chen, Yu-Chao, Li, Wei-Xia, Cao, Meng, Wang, Li-Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504496/
https://www.ncbi.nlm.nih.gov/pubmed/26181041
http://dx.doi.org/10.1371/journal.pone.0132799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504496/
https://www.ncbi.nlm.nih.gov/pubmed/26181041
http://dx.doi.org/10.1371/journal.pone.0132799

Ejemplares similares